SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charles Holewinski who wrote (286)7/23/1997 2:31:00 AM
From: luis a. garcia   of 1115
 
Charlie this is the question we are trying to piece together. From what we see in the patent a topical application does not appear Mutagenic or carcinogenic.. the ingredients are basic and common..
The 10K I just posted was a 95 10K and it shows FDA did not require LIDAK to test as a carcinogen.. no reason to. Frankly Lidak should sue the FDA for all the harm the FDA has done this company.
It is unbelievable we are licencing the inferior European acyclovir all this time... because FDA insistence to have lidak turn medicine into placebo that is outrageuous.
Back to the issue at hand I guess we need more research... a year ago was the issue of the placebo... are you confusing these two issues??
Well I guess maybe I need to look at the 96 10k or actually let me get old company data and see if it shows something about this.....

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext